Protected Innovation
Early-stage patented asset
Innovation through combination
Rather than introducing entirely new molecules, SPORASTAT® combines clinically established active ingredients into a patented formulation designed to address multiple contributors to infection.
Clinical efficacy & patent claims
Our multi-agent composition is engineered to address the complexities of polymicrobial skin and nail infections. We combine synergistic antifungal and antibacterial agents into a single, high-performance formulation designed for superior therapeutic outcomes.
Polymicrobial Efficacy
A multi-agent topical composition specifically engineered to combat a broad spectrum of fungus and bacteria implicated in skin and nail infections.
Synergistic Action
Our formula optimizes the synergy between antifungal, antibacterial, and supportive agents to deliver superior clinical results.
Targeted Delivery
Designed for precise local action, providing high therapeutic efficacy in a cosmestically acceptable, patient-friendly cream formulation.
Freedom to operate (FTO)
Comprehensive prior art and freedom-to-operate analysis confirm a robust IP position. We have identified no blocking patents, ensuring a clear, defensible path for ongoing development and commercialization.
